Есть ли оправдавшие себя БАД?

[Dr.Vad]

и еще, здесь по ссылке

Effect of Omacor on HRV parameters in patients with recent uncomplicated myocardial infarction - A randomized, parallel group, double-blind, placebo-controlled trial: study design [ISRCTN75358739].
Pater C, Compagnone D, Luszick J, Verboom CN.
SourceDepartment of Cardiovascular Clinical Development, Solvay Pharmaceuticals GmbH, Hannover, Germany.

[Ссылки доступны только зарегистрированным пользователям ]

утверждается, что ГИССИ сделано на солвеевском Омакоре:

Results of the GISSI-Prevenzione study [34] (11,323 patients with recent myocardial infarction randomized to Omacor or vitamin E or the combination of the two) showed significantly lower all-cause mortality in the Omacor group, resulting largely from a 45% reduction in sudden cardiac death during 3.5 years of follow-up.